Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Should A Biosimilar Sponsor Do The 'Patent Dance?' It Depends On Many Things

Executive Summary

The amount of exclusivity remaining for a reference product, strength of an innovator's patents and risk of a preliminary injunction are factors that biosimilar sponsors should consider in deciding whether to follow the BPCIA's patent information and exchange procedures, one legal expert suggests.

You may also be interested in...



US FDA's Biosimilars Chief Leah Christl Plans Departure

A departure date has yet to be determined for the associate director of therapeutic biologics, who helped negotiate and implement the biosimilar user fee program.

Biosimilar Global Reference Standard Intrigues US FDA, But Many Questions Still To Answer

Scientific and legal issues still must be resolved before establishing single reference products for biosimilar development, US FDA official says.

Biosimilar Global Reference Standard Intrigues US FDA, But Many Questions Still To Answer

Scientific and legal issues still must be resolved before establishing single reference products for biosimilar development, US FDA official says.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS121297

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel